Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Alopecia totalis/universalis is a severe form of hair loss where all body hair is lost.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

Topical treatments led to hair regrowth in a man with linear morphea.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.